SITE-2 — Los Angeles, California

SITE-2 is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

SITE-2 has participated in 1 clinical trials.

Therapeutic areas: Diffuse Large B Cell Lymphoma Relapsed, Diffuse Large B Cell Lymphoma Refractory.

Sponsors: Pharmacyclics LLC..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SITE-2?

SITE-2 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SITE-2 conducted?

SITE-2 has 1 clinical trials on record. Their work covers Diffuse Large B Cell Lymphoma Relapsed, Diffuse Large B Cell Lymphoma Refractory.

Is SITE-2 accredited by Crixeo Health?

SITE-2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SITE-2?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.